Leptomeningeal changes following lumbar myelography with water-soluble contrast media (meglumine iothalamate and methiodal sodium).
D000272:Adipates / Q000009:adverse effects; D000328:Adult; D000368:Aged; D001100:Arachnoiditis / Q000139:chemically induced* / Q000000981:diagnostic imaging; D001416:Back Pain / Q000209:etiology*; D002908:Chronic Disease; D005260:Female; D005944:Glucosamine / Q000008:administration & dosage; D006801:Humans; D007483:Iothalamic Acid / Q000008:administration & dosage / Q000009:adverse effects*; D008161:Lumbosacral Region; D008698:Mesylates / Q000008:administration & dosage / Q000009:adverse effects*; D008759:Methylglycosides / Q000008:administration & dosage; D009192:Myelography / Q000009:adverse effects*; D013012:Sorbitol / Q000009:adverse effects*; D013118:Spinal Cord Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging
D000272:Adipates; D008698:Mesylates; D008759:Methylglycosides; D007483:Iothalamic Acid; D013012:Sorbitol; D005944:Glucosamine